The Impact of Topical Corticosteroids Used in Conjunction with Antiamoebic Therapy on the Outcome of Acanthamoeba Keratitis


      To examine the impact of topical corticosteroid use after the start of antiamoebic therapy (AAT) on the outcomes of Acanthamoeba keratitis (AK) therapy.


      Cohort study.


      A total of 196 patients diagnosed with AK at Moorfields Eye Hospital, London, between January 1991 and April 2012. In 13 patients with bilateral AK, 1 eye was randomly excluded from analysis.


      Patient demographics and clinical examination findings were collected both at the start of AAT and subsequently at the time that topical corticosteroid therapy was initiated. Preliminary a priori investigations were used to identify effect modifiers/confounders and extreme associations requiring consideration in multivariate regression modeling. A multivariable logistic model, optimized for assessment of corticosteroid use after the start of AAT, was used to estimate the odds ratios (ORs) of a suboptimal outcome.

      Main Outcome Measures

      Suboptimal outcome was defined as final visual acuity ≤20/80, corneal perforation, or the need for keratoplasty.


      In multivariable analysis, restricted to 129 eyes (1 eye per patient) free of scleritis and hypopyon at the start of AAT, topical corticosteroids were not associated with worse outcomes (OR, 1.08; 95% confidence interval [CI], 0.39–3.03), even when corticosteroids had been used before the start of AAT. Risk factors significantly associated with worse outcomes were topical corticosteroid use before the start of AAT (OR, 3.85; 95% CI, 1.35–11.03), a corneal ring infiltrate (together with at least 1 other feature of AK) present at the start of AAT (OR, 5.89; 95% CI, 1.17–29.67), and age ≥33 years at the start of AAT (OR, 4.02; 95% CI, 1.46–11.06).


      Many corneal specialists currently are uncertain about the risk benefit associated with the use of topical corticosteroids for the management of inflammatory complications of AK. The evidence from this study gives clinicians and patients reassurance that the potential benefits of topical corticosteroid therapy, for treating pain and discomfort, are not associated with worse outcomes when initiated after starting modern AAT. Other potential benefits, in terms of resolution of inflammatory complications, will not be demonstrated without a carefully designed randomized clinical trial.

      Abbreviations and Acronyms:

      AAT (antiamoebic therapy), AK (Acanthamoeba keratitis), CI (confidence interval), OR (odds ratio)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal


      Subscribe to Ophthalmology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Dart J.K.
        • Saw V.P.
        • Kilvington S.
        Acanthamoeba keratitis: diagnosis and treatment update 2009.
        Am J Ophthalmol. 2009; 148: 487-499 e2
        • Lee G.A.
        • Gray T.B.
        • Dart J.K.
        • et al.
        Acanthamoeba sclerokeratitis: treatment with systemic immunosuppression.
        Ophthalmology. 2002; 109: 1178-1182
        • Awwad S.T.
        • Heilman M.
        • Hogan R.N.
        • et al.
        Severe reactive ischemic posterior segment inflammation in acanthamoeba keratitis: a new potentially blinding syndrome.
        Ophthalmology. 2007; 114: 313-320
        • Park D.H.
        • Palay D.A.
        • Daya S.M.
        • et al.
        The role of topical corticosteroids in the management of Acanthamoeba keratitis.
        Cornea. 1997; 16: 277-283
        • Oldenburg C.E.
        • Acharya N.R.
        • Tu E.Y.
        • et al.
        Practice patterns and opinions in the treatment of acanthamoeba keratitis.
        Cornea. 2011; 30: 1363-1368
        • Robaei D.
        • Carnt N.
        • Minassian D.C.
        • Dart J.K.
        The impact of topical corticosteroid use before diagnosis on the outcome of Acanthamoeba keratitis.
        Ophthalmology. 2014; 121: 1383-1388
        • Tu E.Y.
        • Joslin C.E.
        • Sugar J.
        • et al.
        Prognostic factors affecting visual outcome in Acanthamoeba keratitis.
        Ophthalmology. 2008; 115: 1998-2003
        • Yamazoe K.
        • Yamamoto Y.
        • Shimazaki-Den S.
        • Shimazaki J.
        Visual outcome in Japanese patients with Acanthamoeba keratitis.
        Eye (Lond). 2012; 26: 517-522
        • Iovieno A.
        • Gore D.M.
        • Carnt N.
        • Dart J.K.
        Acanthamoeba sclerokeratitis: epidemiology, clinical features, and treatment outcomes.
        Ophthalmology. 2014; 121: 2340-2347
        • Chang J.H.
        • Gabison E.E.
        • Kato T.
        • Azar D.T.
        Corneal neovascularization.
        Curr Opin Ophthalmol. 2001; 12: 242-249
        • Thompson Jr., R.W.
        • Price M.O.
        • Bowers P.J.
        • Price Jr., F.W.
        Long-term graft survival after penetrating keratoplasty.
        Ophthalmology. 2003; 110: 1396-1402
        • O’Day D.M.
        • Head W.S.
        Advances in the management of keratomycosis and Acanthamoeba keratitis.
        Cornea. 2000; 19: 681-687
        • Blackman H.J.
        • Rao N.A.
        • Lemp M.A.
        • et al.
        Acanthamoeba keratitis successfully treated with penetrating keratoplasty suggest immunogenic mechanisms of action.
        Cornea. 1984; 3: 125-130
        • Lindquist T.D.
        • Fritsche T.R.
        • Grutzmacher R.D.
        Scleral ectasia secondary to Acanthamoeba keratitis.
        Cornea. 1990; 9: 74-76
        • Holland E.J.
        • Alul I.H.
        • Meisler D.M.
        • et al.
        Subepithelial infiltrates in Acanthamoeba Keratitis.
        Am J Ophthalmol. 1991; 112: 414-418
        • Horsburgh B.
        • Hirst L.W.
        • Carey T.
        • et al.
        Steroid sensitive Acanthamoeba keratitis.
        Aust N Z J Ophthalmol. 1991; 19: 349-350
        • Alizadeh H.
        • Apte S.
        • El-Agha M.S.
        • et al.
        Tear IgA and serum IgG antibodies against Acanthamoeba in patients with Acanthamoeba keratitis.
        Cornea. 2001; 20: 622-627
        • van Klink F.
        • Taylor W.M.
        • Alizadeh H.
        • et al.
        The role of macrophages in Acanthamoeba keratitis.
        Invest Ophthalmol Vis Sci. 1996; 37: 1271-1281
        • Hurt M.
        • Proy V.
        • Niederkorn J.Y.
        • Alizadeh H.
        The interaction of Acanthamoeba castellanii cysts with macrophages and neutrophils.
        J Parasitol. 2003; 89: 565-572
        • Hoti S.L.
        • Tandon V.
        Ocular parasitoses and their immunology.
        Ocul Immunol Inflamm. 2011; 19: 385-396
        • Otri A.M.
        • Mohammed I.
        • Abedin A.
        • et al.
        Antimicrobial peptides expression by ocular surface cells in response to Acanthamoeba castellanii: an in vitro study.
        Br J Ophthalmol. 2010; 94: 1523-1527
        • Ren M.
        • Gao L.
        • Wu X.
        TLR4: the receptor bridging Acanthamoeba challenge and intracellular inflammatory responses in human corneal cell lines.
        Immunol Cell Biol. 2010; 88: 529-536
        • Ren M.Y.
        • Wu X.Y.
        Toll-like receptor 4 signalling pathway activation in a rat model of Acanthamoeba Keratitis.
        Parasite Immunol. 2011; 33: 25-33
        • Shao H.
        • Sun S.L.
        • Kaplan H.J.
        • Sun D.
        Induction of autoimmune encephalomyelitis and uveitis in B6 and (B6 x SJL) mice by peptides derived from myelin/oligodendrocyte glycoprotein.
        J Neuroimmunol. 2002; 132: 117-122
        • McClellan K.
        • Howard K.
        • Niederkorn J.Y.
        • Alizadeh H.
        Effect of steroids on Acanthamoeba cysts and trophozoites.
        Invest Ophthalmol Vis Sci. 2001; 42: 2885-2893
        • Rabinovitch T.
        • Weissman S.S.
        • Ostler H.B.
        • et al.
        Acanthamoeba keratitis: clinical signs and analysis of outcome.
        Rev Infect Dis. 1991; 13: S427
        • Stern G.A.
        • Buttross M.
        Use of corticosteroids in combination with antimicrobial drugs in the treatment of infectious corneal disease.
        Ophthalmology. 1991; 98: 847-853
        • Larkin D.F.
        • Kilvington S.
        • Dart J.K.
        Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide.
        Ophthalmology. 1992; 99: 185-191
        • Bacon A.S.
        • Frazer D.G.
        • Dart J.K.
        • et al.
        A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992.
        Eye. 1993; 7: 719-725
        • Radford C.F.
        • Lehmann O.J.
        • Dart J.K.
        Acanthamoeba keratitis: multicentre survey in England 1992-6. National Acanthamoeba Keratitis Study Group.
        Br J Ophthalmol. 1998; 82: 1387-1392
        • Chawla A.
        • Armstrong M.
        • Carley F.
        Acanthamoeba keratitis - an increasing incidence.
        Cont Lens Anterior Eye. 2014; 37: 120
        • Jasim H.
        • Knox-Cartwright N.
        • Cook S.
        • Tole D.
        Increase in acanthamoeba keratitis may be associated with use of multipurpose contact lens solution.
        BMJ. 2012; 344: e1246
        • Carvalho F.R.
        • Foronda A.S.
        • Mannis M.J.
        • et al.
        Twenty years of acanthamoeba keratitis.
        Cornea. 2009; 28: 516-519
        • Joslin C.E.
        • Tu E.Y.
        • Shoff M.E.
        • et al.
        Shifting distribution of Chicago-area Acanthamoeba keratitis cases.
        Arch Ophthalmol. 2010; 128: 137-139
        • Yoder J.S.
        • Verani J.
        • Heidman N.
        • et al.
        Acanthamoeba keratitis: the persistence of cases following a multistate outbreak.
        Ophthalmic Epidemiol. 2012; 19: 221-225
        • Patel D.V.
        • Rayner S.
        • McGhee C.N.J.
        Resurgence of Acanthamoeba keratitis in Auckland, New Zealand: a 7-year review of presentation and outcomes.
        Clin Exp Ophthalmol. 2010; 38: 15-20
        • Lalitha P.
        • Lin C.C.
        • Srinivasan M.
        • et al.
        Acanthamoeba keratitis in South India: a longitudinal analysis of epidemics.
        Ophthalmic Epidemiol. 2012; 19: 111-115